Blog
RSS FeedPosted by Michael Wonder on 31 Jul 2019
Schedule of Pharmaceutical Benefits - 1 August 2019
1 August 2019 - The August 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Jul 2019
Cancer patients to benefit from subsidies for new medicines
27 July 2019 - Patients will save tens of thousands of dollars a year on the cost of life saving cancer ...
Posted by Michael Wonder on 27 Jul 2019
Australian study evaluates real world evidence of Botox to prevent migraine
26 July 2019 - OnabotulinumtoxinA has been approved by Australia’s reimbursement mechanism for medicines, the PBS, for preventive treatment of ...
Posted by Michael Wonder on 25 Jul 2019
Application process changes for access to Section 100 - Highly Specialised Drugs medicines
25 July 2019 - From 1 August 2019, hospital authorities will no longer be required to seek separate approval from ...
Posted by Michael Wonder on 22 Jul 2019
Australia's National Medicines Policy is outdated and in need of review
22 July 2019 - How will issues such as disruptive innovation, precision medicine and climate change affect Australia's medicines policy ...
Posted by Michael Wonder on 22 Jul 2019
PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting
19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are ...
Posted by Michael Wonder on 22 Jul 2019
Infants with cystic fibrosis to breathe easier with new PBS listing
22 July 2019 - The Australian Government is expanding access to a critically important medicine on the PBS that will help ...
Posted by Michael Wonder on 22 Jul 2019
2019 October price disclosure cycle - indicative prices
22 July 2019 - Indicative 1 October 2019 prices resulting from the 2019 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 21 Jul 2019
A drug that treats cystic fibrosis has been listed on the Pharmaceutical Benefits Scheme
21 July 2019 - A medication to treat cystic fibrosis that costs patients up to $380,000 a year has been added ...
Posted by Michael Wonder on 16 Jul 2019
Irish cystic fibrosis family face €12,400 bill after deportation victory in Australia
15 July 2019 - An Irish family threatened with deportation from Australia because their son has cystic fibrosis have been ...
Posted by Michael Wonder on 15 Jul 2019
Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice
1 July 2019 - The PBS urgently needs to update anti‐epileptic drug prescribing restrictions that put patients and prescribers at ...
Posted by Michael Wonder on 09 Jul 2019
Pharmacists v doctors: fiery prescription debate rages in WA
9 July 2019 - A proposal to allow pharmacists to issue repeat prescriptions should be backed as consumers will save ...
Posted by Michael Wonder on 08 Jul 2019
Family to stay in Australia after son with cystic fibrosis initially deemed a 'burden'
8 July 2019 - A Victorian family at risk of being deported back to their homeland of Ireland after their ...
Posted by Michael Wonder on 07 Jul 2019
Rosemary wants to be the 'Uber' of electronic scripts
8 July 2019 - The former managing director of Dropbox Australia, a Microsoft Health executive and an early Atlassian employee ...
Posted by Michael Wonder on 04 Jul 2019
Pharmacies could hand out prescriptions for medicines under major WA healthcare reforms
5 July 2019 - Pharmacies would be given a dramatically expanded role in the healthcare of WA patients under new ...